FNF vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
FNF presents a conflicted profile with a stable Piotroski F-Score of 4/9 but significant valuation gaps, trading at $52.33 against a Graham Number of $36.91 and an Intrinsic Value of $15.47. While revenue growth remains strong at 12.3% and the forward P/E of 8.11 is attractive, the company suffers from poor liquidity (Quick Ratio 0.19) and an unsustainable dividend payout ratio of 91.4%. The disconnect between bullish analyst targets ($64.60) and bearish deterministic metrics suggests a high-risk premium. Overall, the stock is fundamentally overvalued relative to its defensive baseline despite positive top-line growth.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
FNF vs JPM: Head-to-Head Comparison
This page compares Fidelity National Financial, Inc. (FNF) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.